Dopamine function in obsessive compulsive disorder: Cortisol response to acute apomorphine stimulation

Psychoneuroendocrinology

Volumn 25, Issue 3, 2000, Pages 301-310

  Brambilla, F ^a   Perna, G ^a   Bussi, R ^a   Bellodi, L ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Apomorphine test; Cortisol; Dopamine function; Obsessive compulsive disorder

Indexed keywords

APOMORPHINE; HYDROCORTISONE;

ADOLESCENT; ADULT; ARTICLE; BRAIN REGION; CIRCADIAN RHYTHM; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FEMALE; HORMONE DETERMINATION; HORMONE RELEASE; HORMONE RESPONSE; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; MALE; OBSESSION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; APOMORPHINE; AREA UNDER CURVE; CIRCADIAN RHYTHM; DOPAMINE; DOPAMINE AGONISTS; FEMALE; HUMANS; HYDROCORTISONE; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER;

EID: 0033983796     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(99)00061-X     Document Type: Article

References (48)

1. Almeida, O.F.X., Ali, S., Holsboer, F., Patchev, K., 1997. Activational effects of gonadal steroids on hypothalamo-pituitary-adrenal regulation in the rat disclosed by response to dexamethasone suppression. J. Neuroendocrinol. 9, 129-134.
2. Altemus, M., Pigott, Kalogeras, K.T., Demitrack, M., Dubbert, B., Murphy, D.L., Gold, P.W., 1992. Abnormalities in the regulation of vasopressin and corticotropin-releasing factor secretion in obsessive-compulsive disorder. Arch. Gen. Psychiatry 49, 9-20.
3. Altemus, M., Michelson, D., Galliven, E., Gold, P.W, Murphy, D., 1993. Reduced peripheral HPA axis activity in OCD. Biol. Psychiatry 33, 145A (abstract).
4. Altschuler, M., 1962. Massive doses of trifluoperazine in the treatment of compulsive rituals. Am. J. Psychiatry 19, 376-379.
5. American Psychiatry Association, 1987. Diagnostic and statistical manual for mental disorders, third ed. rev. American Psychiatric Press, Washington DC.
6. Bailly, D., Servant, D., Dewailly, D., Beuscart, R., Racadot, A., Fossati, P., Parquet, P.J., 1994. Corticotropin releasing factor stimulation test in obsessive-compulsive disorder. Biol. Psychiatry 35, 143-146.
7. Benkelfat, C., Mefford, I.N., Masters, C.F., 1991. Plasma catecholamines and their metabolites in obsessive compulsive disorder. Psychiatry Res. 37, 321-322.
8. Borowsky, B., Kuhn, C.M., 1991. Monoamine mediation of cocaine-induced hypothalamo-pituitary-adrenal activation. J. Pharmacol. Exp. Therapeutics 256, 204-210.
9. Borowsky, B., Kuhn, C.M., 1992. D-1 and D-2 dopamine receptors stimulate hypothalamo-pituitary-adrenal activity in rats. Neuropharmacology 31, 671-678.
10. Brambilla, F., Bellodi, L., Perna, G., Arancio, C., Bertani, A., 1997. Dopamine function in obsessive-compulsive disorder: growth hormone response to apomorphine stimulation. Biol. Psychiatry 42, 889-897.
11. Brown, W.A., Krieger, D.T., Van Woert, M.H., Amban, L.M., 1974. Dissociation of growth hormone and cortisol release following apomorphne. J. Clin. Endocrinol. Metab. 38, 1127-1129.
12. Bruto, V., Beauchamp, C., Zacharko, R.M., Anisman, H., 1988. Amphetamine-induced perseverative behavior in a radial arm maze following DSP-4 or 6-OH-DA pretreatment. Psychopharmacology (Berlin) 83, 62-69.
13. Buckingham, J.C., Hodges, J.R., 1977. Production of corticotropin releasing hormone by the isolated hypothalamus of the rat. J. Physiol. 272, 469-479.
14. Calogero, A.E., Gallucci, W.T., Kling, M.A., Chrousos, G.P., Gold, P.W., 1989. Cocaine stimulates rat hypothalamic corticotropin-releasing hormone secretion in vitro. Brain Res. 505, 7-11.
15. Casolini, P., Kabbaj, M., Leprat, F., Piazza, P.V., Rougé-Pont, F., Angelucci, L., Simon, H., Le Moal, M., Maccari, S., 1993. Basal and stress-induced corticosterone secretion is decreased by lesion of mesencefalic dopaminergic neurons. Brain Res. 622, 311-314.
16. Chambers, J.W., Brown, G.M., 1976. Neurotransmitter regulation of growth hormone and ACTH in the rhesus monkey: effects of biogenic amines. Endocrinology 98, 420-428.
17. Coryell, W.H., Black, D.W., Kelly, M.W., Noyes. R. Jr, 1989. HPA axis disturbances in obsessive-compulsive disorders. Neuropsychobiology 30, 243-258.
18. De Simoni, M.G., Dal Toso, G., Fedritto, F., Sokola, A., Algeri, S., 1987. Modulation of striatal dopamine metabolism by the activity of dorsal raphe serotoninergic afferences. Brain Res. 186, 1-7.
19. Eilam, D., Golani, I., Szechtman, H., 1989. D-2 agonist quinpirole induces perseveration of routes and hyperactivity but no perseveration of movements. Brain Res. 490, 255-267.
20. Fehm, H.L., Voigt, K.H., Lang, R.E., Pfeiffer, E.F., 1980. Effects of neurotransmitters on the release of corticotropin releasing hormone (CRH) by rat hypothalamic tissue in vitro. Exp. Brain Res. 39, 229-234.
21. Ferrini, M., Lima, A., De Nicola, A.F., 1995. Estradiol abolishes autologous down regulation of glucocorticoid receptors in brain. Life Sci. 57, 2403-2412.
22. Finenberg, N.A., Cowen, P.J, Kirk, J.W., Montgomery, S.A., 1994. Neuroendocrine responses to intravenous L-triptophan in obsessive compulsive disorder. J. Affect. Disord. 32, 97-104.
23. Freeman, G.B., Thurmond, J.B., 1986. Monoamines and effects of chlordiazepoxide on the corticosterone response to stress. Physiol. Behav. 37, 933-938.
24. Fuller, R.W., Snoddy, H.D., 1981. Elevation of serum corticosterone concentrations in rats by pergolide and other dopamine agonists. Endocrinology 109, 1026-1032.
25. Gehris T.L., Kathol R.G., Black D.W., Noyes R. Jr, 1990 Urinary free cortisol in obsessive-compulsive disorder. Psychiatry Res. 32, 151-158.
26. Goeders, N.E., 1997. A neuroendocrine role in cocain reinforcement. Psychoneuroendocrinology 4, 237-259.
27. Goodman, W.K., Price, L.H., Rasmussen, S.A., Mazure, C., Fleiscman, R.L., Hill, C.L., Heninger, G.R., Charney, D.S., 1989. The Yale-Brown obsessive-compulsive scale: I. Development, use and reliability. Arch. Gen. Psychiatry, 46, 36-43.
28. Goodman W.K., McDougle C.J., Price L.H., Riddle M.A., Pauls D.L., Leckman J.F., 1990. Behiond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder? J. Clin. Psychiatry 51, 36-43.
29. Goodman, W.K., McDougle, C.J., Price, L.H., 1992. The role of serotonin and dopamine in the pathophysiology of obsessive compulsive disorder. Int. Clin. Psychopharmacol. 7 (suppl. 1), 35-38.
30. Greenberg, D., 1987. Compulsive hoarding. Am. J. Psychiatry 41, 409-416.
31. Holland, F.J., Richards, H., Kaplan, S.L., Ganong, W.F., Grumbach, M.M., 1978. The role of biogenic amines in the regulation of growth hormone and corticotropin secretion in the trained conscious dog. Endocrinology 102, 1452-1457.
32. Hollander, E., Stein, D.J., Saoud, J.B., De Caria, C.M., Cooper, T.B., Trungold, S., Stanley, M., Liebowitz, M.R., 1991. Effects of fenfluramine on HVA in OCD and controls. Biol. Psychiatry 29, 104A.
33. Jezova, D., Jurcovicova, J., Vigas, M., Murgas, K. & Labrie, F., 1985. Increase in plasma ACTH after dopaminergic stimulation in rats. Psychopharmacology 85, 201-203.
34. Jezova, D., Vigas, M., 1988. Apomorphine injection stimulates β-endorphin, adrenocorticotropin and cortisol release in healthy man. Psychoneuroendocrinology 13, 479-485.
35. Kitchen, I., Kelly, M., Turner, M., 1988. Dopamine receptor modulation of corticosterone secretion in neonatal and adult rats. J. Pharm. Pharmacol. 40, 580-581.
36. Lal, S., 1988. Apomorphine in the evaluation of dopaminergic function in man. Progress Neuropsychopharmacol. Biol. Psychiatry 12, 117-164.
37. Marazziti, D., Hollander, E., Lensi, P., Ravagli, S., Cassano, B.J., 1992. Peripheral markers of serotonin and dopamine function in obsessive-compulsive disorders. Psychiatry Res. 42, 41-52.
38. McDougle, C.J., Goodman, W.K., Leckman, J.F., Lee, N.C., Heninger, G.R., Price, L.H., 1990. Neuroleptic addition in fluvoxamine-refractory obsessive compulsive disorder. Am. J. Psychiatry 147, 652-654.
39. McDougle, C.J., Goodman, W.K., Leckman, J.F., Lee, N.C., Heninger, G.R., Price, L.H., 1994. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. Arch. Gen. Psychiatry 51, 302-308.
40. Mokrani, M.C., Duvalo, F., Crocq, M.A., Bailey, P.E., Macher, J.P., 1995. Multihormonal responses to apomorphine in mental illness. Psychoneuroendocrinology 20, 365-375.
41. Monteleone, P., Catapano, P., Del Buono, G., Maj, M., 1994. Circadian rhythm of melatonin, cortisol and prolactin in patients with obsessive-compulsive disorder. Acta Psychiatrica Scandinavica 89, 411-415.
42. Rivers-Buckeley, N., Hollender, M.H., 1982. Successful treatment of obsessive compulsive disorder with clozapine. Am. J. Psychiatry 139, 1345-1346.
43. Robins, L., Helzer J.E., Cottler L., Goldring E., 1989. NIMH Diagnosis Interview Schedule: Version III-R. St. Louis, Washington University Medical School, USA.
44. Seaman, P., Van Tol, H.H.M., 1993. Dopamine receptors pharmacology. Curr. Opin. Neurol. Neurosurg. 6, 602-608.
45. Sibley, D.R., Monsma, F.J., 1992. Molecular biology of dopamine receptors. Trends Pharmacol. Sci. 13, 61-69.
46. Sowers, G.R., Beck, F.W., Stern, N., Asp, N., 1983. Effects of metoclopramide on plasma corticosteroid levels in sheep. Endocrinology 113, 903-906.
47. Swedo, S.E., Leonard, H.L., Kruesi, M.J.P., Rettew, D.C., Listwak, S.J., Berrettini, W., Stipetic, M., Hamburger, S., Gold, P.W., Potter, W.S., Rapaport, J.L., 1992. Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder. Arch. Gen. Psychiatry 49, 29-36.
48. Thoren, P., Asberg, M., Mellstrom, B., Sjoqvrist, F., Trackman, L., 1980. Clomipramine treatment of obsessive-compulsive disorders: II Biochemical aspects. Arch. Gen. Psychiatry 37, 1289-1294.